Cosmos Health Future Growth
Future criteria checks 1/6
Cosmos Health is forecast to grow earnings and revenue by 154.4% and 18.3% per annum respectively while EPS is expected to grow by 148% per annum.
Key information
154.4%
Earnings growth rate
148.0%
EPS growth rate
| Healthcare earnings growth | 17.5% |
| Revenue growth rate | 18.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 26 Nov 2024 |
Recent future growth updates
Recent updates
Market Might Still Lack Some Conviction On Cosmos Health Inc. (NASDAQ:COSM) Even After 31% Share Price Boost
Jan 18
Positive Sentiment Still Eludes Cosmos Health Inc. (NASDAQ:COSM) Following 26% Share Price Slump
Aug 16Slammed 27% Cosmos Health Inc. (NASDAQ:COSM) Screens Well Here But There Might Be A Catch
Feb 23Cosmos Holdings intends to acquire telemedicine platform ZipDoctor
Sep 28Cosmos Holdings reports Q2 results
Aug 22Cosmos changes name to Cosmos Healthto
Jul 29Cosmos climbs 11% on Cana Laboratories acquisition, expanding product line and integrating vertically
Jul 20Cosmos Holdings to acquire bone health product portfolio from LIFE NLB
Jul 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 68 | 0 | N/A | 2 | 1 |
| 12/31/2024 | 55 | -9 | N/A | -2 | 1 |
| 9/30/2024 | 56 | -34 | -7 | -3 | N/A |
| 6/30/2024 | 56 | -29 | -14 | -8 | N/A |
| 3/31/2024 | 56 | -27 | -22 | -13 | N/A |
| 12/31/2023 | 53 | -26 | -25 | -16 | N/A |
| 9/30/2023 | 50 | -43 | -33 | -27 | N/A |
| 6/30/2023 | 49 | -42 | -27 | -24 | N/A |
| 3/31/2023 | 50 | -59 | -19 | -19 | N/A |
| 12/31/2022 | 50 | -64 | -15 | -15 | N/A |
| 9/30/2022 | 54 | -35 | -7 | -6 | N/A |
| 6/30/2022 | 56 | -35 | -9 | -8 | N/A |
| 3/31/2022 | 58 | -19 | -10 | -9 | N/A |
| 12/31/2021 | 56 | -16 | -8 | -7 | N/A |
| 9/30/2021 | 56 | -7 | -8 | -7 | N/A |
| 6/30/2021 | 57 | -5 | -8 | -8 | N/A |
| 3/31/2021 | 55 | -1 | -11 | -11 | N/A |
| 12/31/2020 | 55 | 1 | -12 | -12 | N/A |
| 9/30/2020 | 51 | 2 | -12 | -12 | N/A |
| 6/30/2020 | 46 | -1 | -8 | -8 | N/A |
| 3/31/2020 | 42 | -4 | -6 | -5 | N/A |
| 12/31/2019 | 40 | -3 | -5 | -5 | N/A |
| 9/30/2019 | 36 | -13 | -4 | -3 | N/A |
| 6/30/2019 | 34 | -9 | -4 | -3 | N/A |
| 3/31/2019 | 35 | -6 | -1 | 0 | N/A |
| 12/31/2018 | 37 | -9 | -2 | -2 | N/A |
| 9/30/2018 | 40 | -2 | -5 | -5 | N/A |
| 6/30/2018 | 41 | -6 | N/A | -7 | N/A |
| 3/31/2018 | 38 | -7 | N/A | -10 | N/A |
| 12/31/2017 | 30 | -6 | N/A | -9 | N/A |
| 9/30/2017 | 23 | -3 | N/A | -7 | N/A |
| 6/30/2017 | 15 | -3 | N/A | -5 | N/A |
| 3/31/2017 | 10 | -3 | N/A | -3 | N/A |
| 12/31/2016 | 7 | -1 | N/A | -2 | N/A |
| 9/30/2016 | 4 | -7 | N/A | -1 | N/A |
| 6/30/2016 | 3 | -7 | N/A | 0 | N/A |
| 3/31/2016 | 2 | -7 | N/A | 0 | N/A |
| 12/31/2015 | 1 | -7 | N/A | 0 | N/A |
| 9/30/2015 | 0 | -1 | N/A | -1 | N/A |
| 6/30/2015 | 6 | 4 | N/A | 6 | N/A |
| 3/31/2015 | 7 | 5 | N/A | 6 | N/A |
| 12/31/2014 | 8 | 6 | N/A | 7 | N/A |
| 9/30/2014 | 9 | 7 | N/A | 7 | N/A |
| 6/30/2014 | 3 | 2 | N/A | 1 | N/A |
| 3/31/2014 | 2 | 1 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COSM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: COSM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: COSM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: COSM's revenue (18.3% per year) is forecast to grow faster than the US market (8.8% per year).
High Growth Revenue: COSM's revenue (18.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if COSM's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 23:32 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Cosmos Health Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Howard Halpern | Taglich Brothers, Inc. |